ReviewComputational and structural biotechnology journal2021

CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer.

Desh Deepak Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.